- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lymphangioleiomyomatosis (LAM)
Total 1349 results
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLeiomyomatosisUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
University of CincinnatiNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD); FDA Office of Orphan Products DevelopmentCompletedLymphangioleiomyomatosisUnited States, Canada, Japan
-
Medical University of South CarolinaColumbia UniversityCompleted
-
AI Therapeutics, Inc.CompletedLymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticUnited States
-
Nantes University HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeFrance
-
The University of Hong KongUnknownAML | FLT3-ITD MutationHong Kong
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosisFrance, United States, Italy
-
Ludwig-Maximilians - University of MunichCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedLymphangioleiomyomatosis (LAM)United States
-
Schön Klinik Berchtesgadener LandCompletedLymphangioleiomyomatosis | Pulmonary Rehabilitation | LAMGermany
-
University Hospital, BordeauxNot yet recruitingLeukemia, Myeloid, Acute
-
King's College LondonKing's College Hospital NHS TrustUnknownMyelodysplastic Syndromes | Leukemia, Myeloid, Acute
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAscites | Lymphangioleiomyomatosis | Lymphangiomyomas | Pleural EffusionsUnited States
-
David IberriTerminatedAcute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults | AML (Adult) With 11q23 (MLL) Abnormalities | AML (Adult) With Del (5q) | AML (Adult) With Inv (16) (p13; q22) | AML (Adult) With t (16;16) (p13; q22) | AML (Adult) With t (8; 21) (q22; q22) and other conditionsUnited States
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruiting
-
Zunyi Medical CollegeRecruiting
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingTuberous Sclerosis Complex | LymphangioleiomyomatosisUnited States
-
Essen BiotechNot yet recruitingAcute Myeloid Leukemia | AML | AML, Adult | AML, Adult RecurrentChina
-
Bezmialem Vakif UniversityCompletedLabor Complication | AvulsionTurkey
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., LtdRecruiting
-
Beijing Immunochina Medical Science & Technology...Not yet recruiting
-
Zhejiang UniversityShanghai Zeke Biotechnology Co.,LtdTerminated
-
Grupo Argentino de Tratamiento de la Leucemia AgudaCompleted
-
Zhejiang UniversityHangzhou Qihangene Biotech Co.,Ltd.Recruiting
-
BioSight Ltd.Recruiting
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
Zhejiang UniversityNot yet recruiting
-
Zhejiang UniversityNot yet recruiting
-
Zhejiang UniversityNot yet recruiting
-
Zhejiang UniversityNot yet recruiting
-
Aptevo TherapeuticsWithdrawn
-
Martin-Luther-Universität Halle-WittenbergUnknown
-
Nantes University HospitalCompleted
-
AvenCell Europe GmbHGCP-Service International Ltd. & Co. KGTerminatedAcute Myeloid Leukemia | Relapsed AML | Refractory AMLGermany
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
Agios Pharmaceuticals, Inc.Approved for marketingAcute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedTuberous Sclerosis | Lymphangioleiomyomatosis | LymphangioleiomyomasUnited States
-
Clavis PharmaSyneos Health; Theradex; CardiaBase; Learn & ConfirmCompletedRelapsed/Refractory AMLUnited Kingdom, Spain
-
Zhejiang UniversityHangzhou Qihan Biotech Co.,Ltd.Recruiting
-
Rambam Health Care CampusUnknown
-
Elixir Medical CorporationCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
Therapeutic Advances in Childhood Leukemia ConsortiumBristol-Myers SquibbActive, not recruitingAML, ChildhoodUnited States